GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bioretec Ltd (OHEL:BRETEC) » Definitions » EV-to-FCF

Bioretec (OHEL:BRETEC) EV-to-FCF : -9.56 (As of Dec. 11, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Bioretec EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Bioretec's Enterprise Value is €48.31 Mil. Bioretec's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €-5.05 Mil. Therefore, Bioretec's EV-to-FCF for today is -9.56.

The historical rank and industry rank for Bioretec's EV-to-FCF or its related term are showing as below:

OHEL:BRETEC' s EV-to-FCF Range Over the Past 10 Years
Min: -157.12   Med: -15.57   Max: -7.92
Current: -10.12

During the past 6 years, the highest EV-to-FCF of Bioretec was -7.92. The lowest was -157.12. And the median was -15.57.

OHEL:BRETEC's EV-to-FCF is ranked worse than
100% of 373 companies
in the Medical Devices & Instruments industry
Industry Median: 28.76 vs OHEL:BRETEC: -10.12

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-11), Bioretec's stock price is €2.16. Bioretec's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.170. Therefore, Bioretec's PE Ratio (TTM) for today is At Loss.


Bioretec EV-to-FCF Historical Data

The historical data trend for Bioretec's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioretec EV-to-FCF Chart

Bioretec Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - - -12.04 -7.37 -11.40

Bioretec Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - -7.37 - -11.40 -

Competitive Comparison of Bioretec's EV-to-FCF

For the Medical Devices subindustry, Bioretec's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bioretec's EV-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bioretec's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Bioretec's EV-to-FCF falls into.



Bioretec EV-to-FCF Calculation

Bioretec's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=48.309/-5.051
=-9.56

Bioretec's current Enterprise Value is €48.31 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bioretec's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 was €-5.05 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bioretec  (OHEL:BRETEC) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Bioretec's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.16/-0.170
=At Loss

Bioretec's share price for today is €2.16.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Bioretec's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was €-0.170.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Bioretec EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Bioretec's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bioretec Business Description

Traded in Other Exchanges
N/A
Address
Yrittajankulma 5, Tampere, FIN, FI-33710
Bioretec Ltd is a medical device company focusing on the development of safe, and reliable bioabsorbable and bioresorbable implants for pediatric and adult orthopedics. The company's products are used world wide and continue to further develop materials and products for high-load-bearing clinical applications. Some of its brands include RemeOs, Activa IM-N, ActivaPi, and ActivaScrew.

Bioretec Headlines

No Headlines